Literature DB >> 19099271

[Immunology of allergic contact dermatitis].

A S Lonsdorf1, A H Enk.   

Abstract

Eczema is one of the most common skin diseases in dermatological practice. The broad medical definition of eczema includes any acute but non-infectious inflammatory reaction of the skin. The relative homogeneity of both the clinical and histological manifestations of eczema is in stark contrast to the profound pathogenetic differences of its various forms. The group of contact dermatitis can be divided into two main categories: irritant and allergic. Irritant contact dermatitis is due to a principally non- immunological inflammatory reaction of the skin to various physical or chemical irritants. In sharp contrast, allergic contact dermatitis is an antigen-specific cellular immune response of the skin, which in general requires prior antigen-recognition and priming of immune cells. A comprehensive understanding of the complex interactions between immune cells, inflammatory mediators and adhesion molecules in the underlying pathogenesis of allergic contact dermatitis is key for a better functional understanding and the development of new therapeutic strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19099271     DOI: 10.1007/s00105-008-1642-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  57 in total

1.  Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens.

Authors:  B Ortmann; S Martin; A von Bonin; E Schiltz; H Hoschützky; H U Weltzien
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

Review 2.  The role of epidermal cytokines in inflammatory skin diseases.

Authors:  D N Sauder
Journal:  J Invest Dermatol       Date:  1990-11       Impact factor: 8.551

3.  Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis.

Authors:  Hitoshi Akiba; Jeanne Kehren; Marie-Thérèse Ducluzeau; Maya Krasteva; Françoise Horand; Dominique Kaiserlian; Fumio Kaneko; Jean-François Nicolas
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

4.  Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization.

Authors:  Hideki Watanabe; Samuel Gehrke; Emmanuel Contassot; Stéphanie Roques; Jürg Tschopp; Peter S Friedmann; Lars E French; Olivier Gaide
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 5.  The CC chemokine CCL20 and its receptor CCR6.

Authors:  Evemie Schutyser; Sofie Struyf; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

Review 6.  The interleukin-1 axis and cutaneous inflammation.

Authors:  T S Kupper; R W Groves
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

7.  Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression.

Authors:  R W Groves; M H Allen; E L Ross; J N Barker; D M MacDonald
Journal:  Br J Dermatol       Date:  1995-03       Impact factor: 9.302

8.  CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.

Authors:  Y Reiss; A E Proudfoot; C A Power; J J Campbell; E C Butcher
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

9.  Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells.

Authors:  K Steinbrink; C Sorg; E Macher
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS. II.

Authors:  K Landsteiner; J Jacobs
Journal:  J Exp Med       Date:  1936-09-30       Impact factor: 14.307

View more
  1 in total

Review 1.  Skin immune sentinels in health and disease.

Authors:  Frank O Nestle; Paola Di Meglio; Jian-Zhong Qin; Brian J Nickoloff
Journal:  Nat Rev Immunol       Date:  2009-09-18       Impact factor: 53.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.